The people
What they build
Open roles via the TechTO Job Board
Working at Esplanade Ventures
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. Esplanade Ventures’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Or their own careers page: esplanadeventures.com/careers ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
On the TechTO stage
Every talk is searchable — ask the archive about Esplanade Ventures ↗
About
Esplanade Ventures was founded and seeded by Dr. Sheldon Elman, a physician of forty years' practice and co-founder of Persistence Capital Partners, with Stuart M. Elman. The firm invests at seed to Series A, occasionally Series B, in digital health and healthcare IT — AI-enabled software that reaches patients or clinicians directly, explicitly excluding biotech and invasive devices — and backs companies commercialising in North America, with earlier funds also covering Europe and Israel. Its first fund, Esplanade HealthTech Ventures I, closed oversubscribed at more than C$21 million in June 2021 with Desjardins Group among its investors, and had made 13 investments by that July. The portfolio now lists 22 companies, including binah.ai, Cleerly, Rad AI, Sana Health, Wellth and Neura Health. Ella Seitz, now managing partner, joined TechTO's HealthTO panel in August 2025 on what health-tech founders need from investors and how AI is changing what gets funded.
Backers
A venture firm rather than a venture-backed company. Fund I's limited partners include Desjardins Group; the full LP base is not public.
Quick answers
What does Esplanade Ventures invest in?
Digital health and healthcare IT at seed to Series A, with selective Series B — AI-enabled software that reaches patients or clinicians. It does not invest in biotech or invasive devices.
How big is Esplanade's fund?
Its first fund, Esplanade HealthTech Ventures I, closed oversubscribed at more than C$21 million in June 2021 and had made 13 investments by that July. The firm's site now lists 22 portfolio companies.
Who represented Esplanade at TechTO?
Ella Seitz, now the firm's managing partner, spoke on TechTO's HealthTO panel in August 2025 about investor expectations and AI in health tech.